Product
Group 2
4 clinical trials
4 indications
Indication
Diabetic Macular EdemaIndication
Celiac DiseaseIndication
DexmedetomidineIndication
Patellofemoral Pain SyndromeClinical trial
A Randomized, Double-Masked, Placebo-Controlled, Parallel-Arm Study to Evaluate the Efficacy and Safety of RZ402 in Participants With Diabetic Macular Edema (DME)Status: Active (not recruiting), Estimated PCD: 2024-04-01
Clinical trial
A Phase 1B Open-label/Phase 2 Double-blind Placebo- Controlled Study for Pharmacodynamic (PD) Activity, Pharmacokinetics (PK), Safety, and Tolerability of KAN-101 In Patients With Celiac Disease (CeD)Status: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
The Effectiveness of Adding Dexmedetomidine to Alcohol in Splanchnic Nerve Neurolysis for the Treatment of Intra-Abdominal Cancer Pain.Status: Completed, Estimated PCD: 2022-06-30
Clinical trial
Effects of Mulligan Technique With or Without Diclofenac Phonophoresis on Pain, Range of Motion and Functional Disability of Knee Joint in Patients With Patellofemoral Pain SyndromeStatus: Recruiting, Estimated PCD: 2024-07-01